Aachen

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• IgA nephropathy1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Omeros Corporation3 trials

Running trials

• Active, not recruiting

  Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria

  NCT06298955· Phase 2· Omeros Corporation· Source

Closed trials

• Completed

  Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab

  NCT05972967· Phase 2· Omeros Corporation· Source

• Terminated

  Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

  NCT03608033· Phase 3· Omeros Corporation· Source